egtazic acid has been researched along with Neurodegenerative Diseases in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Glicksman, MA; Huang, MM; Michaelis, ML; Ni, J; Schuman, ER; Seyb, KI | 1 |
Hernández-Fonseca, K; Massieu, L | 1 |
Shah, S; Tear, S | 1 |
Bhat, MB; Bhattacharya, SK; Takahara, H | 1 |
4 other study(ies) available for egtazic acid and Neurodegenerative Diseases
Article | Year |
---|---|
Identification of small molecule inhibitors of beta-amyloid cytotoxicity through a cell-based high-throughput screening platform.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Calcium; Calpain; Cell Death; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Egtazic Acid; Humans; Luminescence; Mass Screening; Neurodegenerative Diseases; Time Factors | 2008 |
Disruption of endoplasmic reticulum calcium stores is involved in neuronal death induced by glycolysis inhibition in cultured hippocampal neurons.
Topics: Adenosine Triphosphate; Animals; Calcium; Calcium Channels; Calcium Signaling; Cell Death; Cell Survival; Cells, Cultured; Chelating Agents; Egtazic Acid; Endoplasmic Reticulum; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+); Glycolysis; Hippocampus; Inositol 1,4,5-Trisphosphate Receptors; Iodoacetates; Nerve Degeneration; Neurodegenerative Diseases; Neurons; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Ryanodine Receptor Calcium Release Channel | 2005 |
Progressive neurodegenerative disease and pain.
Topics: Analgesics; Animals; Caprylates; Cognition Disorders; Egtazic Acid; Humans; Neurodegenerative Diseases; Pain; Parkinson Disease; TRPV Cation Channels | 2005 |
Modulation of peptidyl arginine deiminase 2 and implication for neurodegeneration.
Topics: Animals; Astrocytes; Blotting, Western; Calcium; Cells, Cultured; Chelating Agents; Child; Egtazic Acid; Enzyme Inhibitors; Fluorescent Antibody Technique, Indirect; Humans; Hydrolases; Male; Microscopy, Fluorescence; Neurodegenerative Diseases; Osmotic Pressure; Protein-Arginine Deiminase Type 2; Protein-Arginine Deiminases; Rats; Rats, Sprague-Dawley; Thapsigargin | 2006 |